Orthocell Limited (OCC) 2020年年度报告「ASX」.pdf

1、Appendix 4E Preliminary final Report +See chapter 19 for defined terms 30/06/2016 Appendix 4E Page 1 Rules 4.3A Appendix 4E Preliminary final report Name of entity ORTHOCELL LIMITED ABN or equivalent company reference Financial year ended(current period)57 118 897 135 30 June 2020 For announcement t

2、o the market Current year reported amount$Change up/(down)from previous year$Change up/(down)from previous year%Revenues from product sales 719,523(226,134)(23.9%)Other revenues from continuing operations 199,325(94,389)(32.1%)Total revenues from continuing operations 918,848 (320,523)(25.9%)Loss fr

3、om ordinary activities after tax attributable to members (6,151,029)298,815 5.1%Net loss for the period attributable to members(6,151,029)298,815 5.1%Dividends(distributions)Amount per security Franked amount per security Interim dividend Nil-Final dividend Nil-Previous corresponding period Nil-+Rec

4、ord date for determining entitlements to the dividend,(in the case of a trust,distribution)N/A Net Tangible Assets per share 30 June 2020 30 June 2019 Nettangibleassetbackingperordinarysecurity(centspershare)10.44 5.83 The above results should be read in conjunction with the notes and commentary con

5、tained in this report.Appendix 4E Preliminary final Report +See chapter 19 for defined terms 30/06/2016 Appendix 4E Page 2 Annual meeting(Preliminary final report only)The annual meeting will be held as follows:Place Building 191 Murdoch University Corner of Campus Drive&Discovery Way Murdoch WA 615

6、0 Date On or before 30 November 2020 Time To be advised Approximate date the+annual report will be available On or before 30 October 2020 Compliance statement 1 This report has been prepared in accordance with AASB Standards,other AASB authoritative pronouncements and Urgent Issues Group Consensus V